BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 30919222)

  • 21. Growth-suppressive effect of suberoylanilide hydroxamic acid (SAHA) on human oral cancer cells.
    Jang B; Shin JA; Kim YS; Kim JY; Yi HK; Park IS; Cho NP; Cho SD
    Cell Oncol (Dordr); 2016 Feb; 39(1):79-87. PubMed ID: 26582320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Penfluridol induces endoplasmic reticulum stress leading to autophagy in pancreatic cancer.
    Ranjan A; German N; Mikelis C; Srivenugopal K; Srivastava SK
    Tumour Biol; 2017 Jun; 39(6):1010428317705517. PubMed ID: 28618969
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Select Bcl-2 antagonism restores chemotherapy sensitivity in high-risk neuroblastoma.
    Tanos R; Karmali D; Nalluri S; Goldsmith KC
    BMC Cancer; 2016 Feb; 16():97. PubMed ID: 26874859
    [TBL] [Abstract][Full Text] [Related]  

  • 24. ABT-263 sensitizes TRAIL-resistant hepatocarcinoma cells by downregulating the Bcl-2 family of anti-apoptotic protein.
    Wang G; Zhan Y; Wang H; Li W
    Cancer Chemother Pharmacol; 2012 Mar; 69(3):799-805. PubMed ID: 22037880
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cisplatin-induced apoptosis in non-small-cell lung cancer cells is dependent on Bax- and Bak-induction pathway and synergistically activated by BH3-mimetic ABT-263 in p53 wild-type and mutant cells.
    Matsumoto M; Nakajima W; Seike M; Gemma A; Tanaka N
    Biochem Biophys Res Commun; 2016 Apr; 473(2):490-6. PubMed ID: 26996126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Synthetic Cell-Penetrating Dominant-Negative ATF5 Peptide Exerts Anticancer Activity against a Broad Spectrum of Treatment-Resistant Cancers.
    Karpel-Massler G; Horst BA; Shu C; Chau L; Tsujiuchi T; Bruce JN; Canoll P; Greene LA; Angelastro JM; Siegelin MD
    Clin Cancer Res; 2016 Sep; 22(18):4698-711. PubMed ID: 27126996
    [TBL] [Abstract][Full Text] [Related]  

  • 27. ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor.
    Tse C; Shoemaker AR; Adickes J; Anderson MG; Chen J; Jin S; Johnson EF; Marsh KC; Mitten MJ; Nimmer P; Roberts L; Tahir SK; Xiao Y; Yang X; Zhang H; Fesik S; Rosenberg SH; Elmore SW
    Cancer Res; 2008 May; 68(9):3421-8. PubMed ID: 18451170
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gypenosides suppress growth of human oral cancer SAS cells in vitro and in a murine xenograft model: the role of apoptosis mediated by caspase-dependent and caspase-independent pathways.
    Lu KW; Chen JC; Lai TY; Yang JS; Weng SW; Ma YS; Lin HY; Wu RS; Wu KC; Wood WG; Chung JG
    Integr Cancer Ther; 2012 Jun; 11(2):129-40. PubMed ID: 21665877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Role of transcription factor Sp1 in the 4-O-methylhonokiol-mediated apoptotic effect on oral squamous cancer cells and xenograft.
    Cho JH; Lee RH; Jeon YJ; Shin JC; Park SM; Choi NJ; Seo KS; Yoon G; Cho SS; Kim KH; Cho JJ; Cho YS; Kim DH; Hong JT; Lee TH; Park HJ; Jung S; Seo JM; Chen H; Dong Z; Chae JI; Shim JH
    Int J Biochem Cell Biol; 2015 Jul; 64():287-97. PubMed ID: 25982202
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Novel histone deacetylase inhibitor MPT0G009 induces cell apoptosis and synergistic anticancer activity with tumor necrosis factor-related apoptosis-inducing ligand against human hepatocellular carcinoma.
    Chen MC; Huang HH; Lai CY; Lin YJ; Liou JP; Lai MJ; Li YH; Teng CM; Yang CR
    Oncotarget; 2016 Jan; 7(1):402-17. PubMed ID: 26587975
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endoplasmic reticulum stress-mediated signaling pathway of gastric cancer apoptosis.
    Xu YY; You YW; Ren XH; Ding Y; Cao J; Zang WD; Feng R; Zhang QX
    Hepatogastroenterology; 2012; 59(120):2377-84. PubMed ID: 22688017
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Combined antitumor effect of γ-secretase inhibitor and ABT-737 in Notch-expressing non-small cell lung cancer.
    Sakakibara-Konishi J; Ikezawa Y; Oizumi S; Kikuchi J; Kikuchi E; Mizugaki H; Kinoshita I; Dosaka-Akita H; Nishimura M
    Int J Clin Oncol; 2017 Apr; 22(2):257-268. PubMed ID: 27816990
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Targeting BCL-2 family proteins to overcome drug resistance in non-small cell lung cancer.
    Wesarg E; Hoffarth S; Wiewrodt R; Kröll M; Biesterfeld S; Huber C; Schuler M
    Int J Cancer; 2007 Dec; 121(11):2387-94. PubMed ID: 17688235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Norcantharidin enhances ABT-263-mediated anticancer activity in neuroblastoma cells by upregulation of Noxa.
    Wang X; Gu Z; Li G; Zhang S; Cao Z; Yang Z; Liu G
    Oncol Rep; 2014 Aug; 32(2):716-22. PubMed ID: 24891300
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Endoplasmic reticulum stress activation mediates Ginseng Rg3-induced anti-gallbladder cancer cell activity.
    Wu K; Li N; Sun H; Xu T; Jin F; Nie J
    Biochem Biophys Res Commun; 2015 Oct; 466(3):369-75. PubMed ID: 26361144
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The ratio of Bcl-2/Bim as a predictor of cisplatin response provides a rational combination of ABT-263 with cisplatin or radiation in small cell lung cancer.
    Li H; Wang H; Deng K; Han W; Hong B; Lin W
    Cancer Biomark; 2019; 24(1):51-59. PubMed ID: 30614795
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mcl-1 is an important therapeutic target for oral squamous cell carcinomas.
    Maji S; Samal SK; Pattanaik L; Panda S; Quinn BA; Das SK; Sarkar D; Pellecchia M; Fisher PB; Dash R
    Oncotarget; 2015 Jun; 6(18):16623-37. PubMed ID: 26009874
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cell and molecular determinants of in vivo efficacy of the BH3 mimetic ABT-263 against pediatric acute lymphoblastic leukemia xenografts.
    Suryani S; Carol H; Chonghaile TN; Frismantas V; Sarmah C; High L; Bornhauser B; Cowley MJ; Szymanska B; Evans K; Boehm I; Tonna E; Jones L; Manesh DM; Kurmasheva RT; Billups C; Kaplan W; Letai A; Bourquin JP; Houghton PJ; Smith MA; Lock RB
    Clin Cancer Res; 2014 Sep; 20(17):4520-31. PubMed ID: 25013123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cafestol overcomes ABT-737 resistance in Mcl-1-overexpressed renal carcinoma Caki cells through downregulation of Mcl-1 expression and upregulation of Bim expression.
    Woo SM; Min KJ; Seo BR; Nam JO; Choi KS; Yoo YH; Kwon TK
    Cell Death Dis; 2014 Nov; 5(11):e1514. PubMed ID: 25375379
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ABT-737 potentiates cisplatin-induced apoptosis in human osteosarcoma cells via the mitochondrial apoptotic pathway.
    Zhang F; Yu X; Liu X; Zhou T; Nie T; Cheng M; Liu H; Dai M; Zhang B
    Oncol Rep; 2017 Oct; 38(4):2301-2308. PubMed ID: 28849162
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.